INT324639

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.45
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Abstract
Documents 5
Total Number 5
Disease Relevance 2.67
Pain Relevance 0.19

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (Flt1) endosome (Flt1) Golgi apparatus (Flt1)
plasma membrane (Flt1) nucleus (Flt1) kinase activity (Flt1)
Flt1 (Mus musculus)
Pain Link Frequency Relevance Heat
aspirin 10 89.04 High High
anesthesia 12 5.00 Very Low Very Low Very Low
metalloproteinase 8 5.00 Very Low Very Low Very Low
ketamine 4 5.00 Very Low Very Low Very Low
Inflammation 4 5.00 Very Low Very Low Very Low
ischemia 4 5.00 Very Low Very Low Very Low
Somatostatin 4 5.00 Very Low Very Low Very Low
Kinase C 4 5.00 Very Low Very Low Very Low
headache 1 5.00 Very Low Very Low Very Low
nud 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pre-eclampsia 136 99.76 Very High Very High Very High
Diabetes Mellitus 24 93.80 High High
Hypertension 31 93.08 High High
Burns 40 90.36 High High
Corneal Neovascularization 148 88.80 High High
Injury 24 72.56 Quite High
Obesity 3 51.44 Quite High
Fibromyalgia 2 50.00 Quite Low
Disease 20 5.00 Very Low Very Low Very Low
Cancer 16 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The concentration of sFlt1, sEng and PlGF were all statistically significantly higher at study entry in the women with multifetal gestation compared with subjects with pre-existing diabetes, chronic hypertension and previous preeclampsia (p<0.0001 for all, data not shown).
Transcription (concentration) of sFlt1 associated with diabetes mellitus, hypertension and pre-eclampsia
1) Confidence 0.45 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2952583 Disease Relevance 0.82 Pain Relevance 0.19
In contrast, there were no significant differences in Vegf and Vegfr1 mRNA expression levels between the treatment and control groups (p>0.05 for both).


Transcription (expression) of Vegfr1
2) Confidence 0.41 Published 2010 Journal Molecular Vision Section Abstract Doc Link PMC2913137 Disease Relevance 0.29 Pain Relevance 0
The mRNA expression levels of murine vascular endothelial growth factor (Vegf), VEGF receptor 1 and 2 (Vegfr1, Vegfr2), and vasohibin-1 (Vash1) were analyzed and compared by real time quantitative reverse-transcription polymerase chain reaction.


Transcription (levels) of Vegfr1
3) Confidence 0.41 Published 2010 Journal Molecular Vision Section Abstract Doc Link PMC2913137 Disease Relevance 0.63 Pain Relevance 0
In contrast, there were no significant differences in Vegf and Vegfr1 mRNA expression levels between the treatment and control groups (p>0.05 for both).


Transcription (levels) of Vegfr1
4) Confidence 0.41 Published 2010 Journal Molecular Vision Section Abstract Doc Link PMC2913137 Disease Relevance 0.29 Pain Relevance 0
The mRNA expression levels of murine vascular endothelial growth factor (Vegf), VEGF receptor 1 and 2 (Vegfr1, Vegfr2), and vasohibin-1 (Vash1) were analyzed and compared by real time quantitative reverse-transcription polymerase chain reaction.


Transcription (expression) of Vegfr1
5) Confidence 0.41 Published 2010 Journal Molecular Vision Section Abstract Doc Link PMC2913137 Disease Relevance 0.64 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox